Vivanza Biosciences Confirms No Fundraising, No SEBI Deviation

Vivanza Biosciences Limited has submitted a formal letter to the Department of Corporate Services at BSE Limited. The purpose of the communication is to comply with Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and SEBI Circular No. CIR/CFD/CMD1/162/2019 dated 24th December, 2019.

The company confirms that it has not raised any funds through a Public Issue, Rights Issue, Preferential Issue, or Qualified Institutions Placement (QIP). As a result, the requirement to submit a Statement of Deviation or Variation regarding the use of proceeds from such issuances is not applicable to the company. No such statement is being provided.

The letter was digitally signed by Jayendra Mehta, Managing Director (DIN: 08210602), on behalf of the company.